Sina Oppermann

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.

Journal: Cancer research

Published: June 16, 2024

Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.

Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.

Journal: Journal of neuro-oncology

Published: November 01, 2023

Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids.

Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids.

Journal: IEEE transactions on medical imaging

Published: September 13, 2022

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

Journal: NPJ precision oncology

Published: May 05, 2022

Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.

Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.

Journal: Cancers

Published: December 14, 2021

iTReX: Interactive exploration of mono- and combination therapy dose response profiling data.

iTReX: Interactive exploration of mono- and combination therapy dose response profiling data.

Journal: Pharmacological research

Published: September 10, 2021

Drug-perturbation-based stratification of blood cancer.

Drug-perturbation-based stratification of blood cancer.

Journal: The Journal of clinical investigation

Published: March 08, 2017

BID links ferroptosis to mitochondrial cell death pathways.

BID links ferroptosis to mitochondrial cell death pathways.

Journal: Redox biology

Published: January 27, 2017

Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells.

Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells.

Journal: Oncotarget

Published: August 08, 2016

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.

Journal: Blood

Published: December 20, 2015

Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells--Mitochondrial Outer Membrane Permeabilization and Beyond.

Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells--Mitochondrial Outer Membrane Permeabilization and Beyond.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 19, 2015

Novel N-phenyl-substituted thiazolidinediones protect neural cells against glutamate- and tBid-induced toxicity.

Novel N-phenyl-substituted thiazolidinediones protect neural cells against glutamate- and tBid-induced toxicity.

Journal: The Journal of pharmacology and experimental therapeutics

Published: May 23, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026